SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Director/PDMR Shareholding

7 Mar 2007 16:52

Rentokil Initial PLC07 March 2007 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer Rentokil Initial plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) Pursuant to (i) and (ii) above 3. Name of person discharging managerial responsibilities/director a) Doug Flynn b) Andrew Macfarlane c) Mark Boyle d) Henry Chandler e) Michael Cooke f) Andy Hobart g) Andy Kemp h) David Liu 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person Not applicable 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest Pursuant to 3. above 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary shares of 1 pence each 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Not applicable 8 State the nature of the transaction Awards under the 2006 Performance Share Plan 9. Number of shares, debentures or financial instruments relating to sharesacquired Not applicable - see 17. below 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) Not applicable 11. Number of shares, debentures or financial instruments relating to sharesdisposed Not applicable 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) Not applicable 13. Price per share or value of transaction Not applicable 14. Date and place of transaction Not applicable 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) Not applicable 16. Date issuer informed of transaction Not applicable If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17. Date of grant 6 March 2007 - Performance Share Plan award 18. Period during which or date on which it can be exercised 6 March 2010 to 5 March 2017 (subject to performance conditions) 19. Total amount paid (if any) for grant of the option Nil 20. Description of shares or debentures involved (class and number) Ordinary shares of 1 pence each a) Doug Flynn - 921,502 performance share plan awards b) Andrew Macfarlane - 401,365 performance share plan awards c) Mark Boyle - 188,396 performance share plan awards d) Henry Chandler - 270,307 performance share plan awards e) Michael Cooke - 163,823 performance share plan awards f) Andy Hobart - 258,020 performance share plan awards g) Andy Kemp - 227,713 performance share plan awards h) David Liu - 268,722 performance share plan awards 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise 146.5p 22. Total number of shares or debentures over which options held followingnotification a) Doug Flynn - 921,502 performance share plan awards b) Andrew Macfarlane - 753,197 performance share plan awards c) Mark Boyle - 368,500 performance share plan awards d) Henry Chandler - 492,296 performance share awards e) Michael Cooke - 228,233 performance share plan awards f) Andy Hobart - 496,763 performance share plan awards g) Andy Kemp - 445,514 performance share plan awards h) David Liu - 523,006 performance share plan awards 23. Any additional information Not applicable 24. Name of contact and telephone number for queries Paul Griffiths, Company Secretary - 020 7866 3021 Name and signature of duly authorised officer of issuer responsible for makingnotification Paul Griffiths, Company Secretary - 020 7866 3021 Date of notification 7 March 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.